| |
 |
|
| |
Conceptus has a singular focus: bringing the technological
advances in minimally invasive medicine to the field of reproduction.
Founded in September, 1992, Conceptus is a public company that designs,
manufactures and sells the EssureTM non-incisional permanent birth control
system. The Essure procedure is designed to be a non-incisional alternative to
surgical tubal ligation, the most common form of birth control world-wide.
Headquartered in the United States, the company has twice been awarded "Fastest
Growing Business in Silicon Valley (California)."
With Essure, Conceptus believes it has the technology to transform the field of
permanent birth control, and is seeking approval to market Essure globally.
Currently, Essure has been approved or registered for sale in Australia, the
European Union, Canada, and Singapore. Approval to market in the United States
is expected in 2003. In clinical trials
conducted under strict requirements, Essure has been 99% effective with a
patient satisfaction rating of over 90 percent.
Address and Phone:
1021 Howard Avenue
San Carlos, CA, USA 94070
Phone: (650) 802-7240
Fax: (650) 610-8363
Web site:
www.conceptus.com
Email:
australia@conceptus.com
|
|
 |
Talk to a registered nurse to get more
information about Essure. Call 1 800 785 336. |
|
|
|
 |
|
| Find an Essure trained gynaecologist who is right for you, or
find a knowledgeable general practitioner who can give you a referral. |
 |
|
 |
|